Atea Pharmaceuticals (NASDAQ:AVIR) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Atea Pharmaceuticals (AVIR) operate in?

Atea Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Atea Pharmaceuticals Stock (NASDAQ: AVIR) stock price, news, charts, stock research, profile.

Open	$3.81
Close	$3.90
Volume / Avg.	224.12K / 246.80K
Day Range	$3.80 - $3.95
52 Wk Range	2.77 - 4.60
Market Cap	$329.25M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	60
Short Interest	3.96%
Days to Cover	12.3

Recent News

Atea Pharmaceuticals Shares Promising Data From Therapy Study For Hepatitis C Virus

Atea Pharmaceuticals announces 97% SVR12 in Phase 2 HCV study of bemnifosbuvir. Data shows high efficacy, safety, and low resistance risk.

Vandana Singh

Atea Pharmaceuticals' Hepatitis C Virus Candidate Shows Efficacy

Atea Pharmaceuticals Inc (NASDAQ: AVIR) reported initial data from the first 52 patients in the lead-in cohort of its Phase 2 combination eight-week study of bemnifosbuvir and ruzasvir (RZR) for

Vandana Singh

Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Gainers QualTek Services Inc. (NASDAQ: QTEK) shares jumped 127.2% to $0.1740 after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter 11 bankruptcy.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug

Buy

Hold

Sell

Strong Sell

About Atea Pharmaceuticals Inc

Sector

Health Care

Industry

Pharmaceuticals

Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, devel...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Atea Pharmaceuticals (AVIR) stock?

You can purchase shares of Atea Pharmaceuticals (NASDAQ:AVIR) through any online brokerage.

View our list of the best stock brokerages

Who are Atea Pharmaceuticals (AVIR) competitors?

Other companies in Atea Pharmaceuticals’s space includes: Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), Zevra Therapeutics (NASDAQ:ZVRA), GH Research (NASDAQ:GHRS) and SNDL (NASDAQ:SNDL).

What is the forecast, or price target, for Atea Pharmaceuticals (AVIR) stock?

Atea Pharmaceuticals has a consensus price target of $6.44.

What is the current price for Atea Pharmaceuticals (AVIR)?

The stock price for Atea Pharmaceuticals (NASDAQ: AVIR) is $3.9 last updated August 23, 2024 at 4:00 PM EDT.

Does Atea Pharmaceuticals (AVIR) pay a dividend?

There are no upcoming dividends for Atea Pharmaceuticals.

When is Atea Pharmaceuticals (NASDAQ:AVIR) reporting earnings?

Atea Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 6, 2024.

Is Atea Pharmaceuticals (AVIR) going to split?

There is no upcoming split for Atea Pharmaceuticals.

What sector and industry does Atea Pharmaceuticals (AVIR) operate in?

Atea Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Get Our Top Trade Ideas Delivered Daily - 65% Off Now'

-

-

-

-

-

-

-